Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hirsch, Hans
Shingr'HIV, NCT05575830: Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls	Recruiting	4	225	Europe	Recombinant Zoster Vaccine, (Shingrix® )	Calmy Alexandra	RZV Vaccine (Shingrix ®)	09/24	09/25
NCT04351503: A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19	Completed	N/A	126586	Europe	Study A, Study B, Study C, Study D	University Hospital, Basel, Switzerland, sciCORE University of Basel, Leonhard Med IT ETH Zurich, Swiss Institute of Bioinformatics	SARS Coronavirus (SARS-CoV-2) Infection	07/22	07/22
NCT04172025: Development of a Swiss Surveillance Database for Molecular Epidemiology of Hypervirulent and Multi-drug Resistant Pathogens	Recruiting	N/A	10000	Europe	Analysis of Bacterial Genome	University Hospital, Basel, Switzerland, Swiss National Science Foundation	Multiresistant Bacterial Pathogens, Virulent Bacterial Pathogens	12/29	12/29